Viatris
VTRS
VTRS
530 hedge funds and large institutions have $18.1B invested in Viatris in 2018 Q1 according to their latest regulatory filings, with 69 funds opening new positions, 157 increasing their positions, 208 reducing their positions, and 74 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
1% less funds holding
Funds holding: 537 → 530 (-7)
9% less funds holding in top 10
Funds holding in top 10: 22 → 20 (-2)
25% less repeat investments, than reductions
Existing positions increased: 157 | Existing positions reduced: 208
Holders
530
Holding in Top 10
20
Calls
$549M
Puts
$400M
Top Buyers
| 1 | +$249M | |
| 2 | +$211M | |
| 3 | +$199M | |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$190M |
| 5 |
Goldman Sachs
New York
|
+$136M |
Top Sellers
| 1 | -$144M | |
| 2 | -$113M | |
| 3 | -$104M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$99M |
| 5 |
SIG
Senator Investment Group
New York
|
-$84.6M |